Upregulation of Fibroblast Growth Factors Caused by Heart and Neural Crest Derivatives Expressed 2 Suppression in Endometriotic Cells: A Possible Therapeutic Target in Endometriosis
Restricted accessResearch articleFirst published online July, 2019
Upregulation of Fibroblast Growth Factors Caused by Heart and Neural Crest Derivatives Expressed 2 Suppression in Endometriotic Cells: A Possible Therapeutic Target in Endometriosis
Several features exist that distinguish endometriotic cells from eutopic endometrial cells. Progesterone resistance is one of the main distinguishing features, although how progesterone resistance affects the phenotype of endometriotic cells is not fully elucidated. Heart and neural crest derivatives expressed 2 (HAND2) is a transcriptional factor that plays an important role in maintaining endometrial function in a progesterone-dependent manner. Therefore, we explored whether progesterone-dependent HAND2 is implicated in the progression of endometriosis. HAND2 was less expressed by endometriotic tissues compared to endometrial tissues. Suppression of HAND2 expression induced fibroblast growth factor 1 (FGF1), FGF2, and FGF9 in endometriotic stromal cells and consequently enhanced migration and invasion capacity. AZD4547, a FGF receptor inhibitor, diminished the migration and invasion of endometriotic cells in vitro. In the murine model of endometriosis, AZD4547 showed suppressive effects on the development of endometriotic lesions at a relatively low concentration. In conclusion, we demonstrated that FGF1, FGF2, and FGF9 are downstream effectors of HAND2 in endometriotic cells. Since HAND2-dependent FGFs play roles in enhancing invasive capacity of endometriotic cells, our results suggest that FGF receptor inhibitors, such as AZD4547, can be promising therapeutic targets for endometriosis.
BulunSE. Endometriosis. N Engl J Med. 2009;360(3):268–279.
2.
EskenaziBWarnerML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24(2):235–258.
3.
de ZieglerDBorgheseBChapronC. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742):730–738.
4.
HoustonDE. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev. 1984;6:167–191.
5.
FauconnierAChapronC. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005;11(6):595–606.
6.
Al-SabbaghMLamEWBrosensJJ. Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol. 2012;358(2):208–215.
7.
AttiaGRZeitounKEdwardsDJohnsACarrBRBulunSE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000;85(8):2897–2902.
8.
BurneyROTalbiSHamiltonAE. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(8):3814–3826.
9.
AghajanovaLHorcajadasJAWeeksJL. The protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts reveals compromised differentiation and persistent proliferative potential in endometriosis. Endocrinology. 2010;151(3):1341–1355.
10.
IwaseAKotaniTGotoM. Possible involvement of CD10 in the development of endometriosis due to its inhibitory effects on CD44-dependent cell adhesion. Reprod Sci. 2014;21(1):82–88.
11.
KaoLCGermeyerATulacS. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144(7):2870–2881.
12.
LiuNBarbosaACChapmanSL. DNA binding-dependent and -independent functions of the HAND2 transcription factor during mouse embryogenesis. Development. 2009;136(6):933–942.
13.
LiQKannanADeMayoFJ. The antiproliferative action of progesterone in uterine epithelium is mediated by HAND2. Science. 2011;331(6019):912–916.
14.
ShindohHOkadaHTsuzukiTNishigakiAKanzakiH. Requirement of heart and neural crest derivatives-expressed transcript 2 during decidualization of human endometrial stromal cells in vitro. Fertil Steril. 2014;101(6):1781–1790. e1781–e1785.
15.
CaoRBrakenhielmEPawliukR. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9(5):604–613.
16.
ForoughRXiZMacPheeM. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J Biol Chem. 1993;268(4):2960–2968.
17.
NesbitMNesbitHKBennettJ. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene. 1999;18(47):6469–6476.
18.
WuMHShojiYChuangPCTsaiSJ. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med. 2007;9(2):1–20.
19.
IwaseAHirokawaWGotoM. Serum anti-mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril. 2010;94(7):2846–2849.
20.
IwaseAAndoHNagasakaT. Neutral endopeptidase expressed by decidualized stromal cells suppresses akt phosphorylation and deoxyribonucleic acid synthesis induced by endothelin-1 in human endometrium. Endocrinology. 2006;147(11):5153–5159.
21.
KobayashiHYamashitaYIwaseA. The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis. Fertil Steril. 2012;98(2):415–422. e411–e412.
22.
IshidaCMoriMNakamuraK. Non-thermal plasma prevents progression of endometriosis in mice. Free Radic Res. 2016;50(10):1131–1139.
23.
SampsonJA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol1927;14(4):422–469.
24.
AghajanovaLVelardeMCGiudiceLC. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010;28(1):51–58.
25.
Gonzalez-RamosRDefrereSDevotoL. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil Steril. 2012;98(3):520–528.
26.
AdachiMNasuKTsunoAYugeAKawanoYNaraharaH. Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2011;155(1):85–88.
27.
ChangJWangSZhangZ. Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer. Oncotarget. 2015;6(4):2009–2022.
28.
ZhangJZhangLSuX. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models. Clin Cancer Res. 2012;18(24):6658–6667.
29.
GavinePRMooneyLKilgourE. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res. 2012;72(8):2045–2056.
30.
SakaHKitagawaCKogureY. Safety, tolerability, and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study. Invest New Drugs. 2017;35(4):451–462.
31.
PaikPKShenRBergerMF. A Phase Ib Open-Label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers. Clin Cancer Res. 2017;23(18):5366–5373.
32.
TostiCPinzautiSSantulliPChapronCPetragliaF. Pathogenetic mechanisms of deep infiltrating endometriosis. Reprod Sci. 2015;22(9):1053–1059.
33.
ChapronCTostiCMarcellinL. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod. 2017;32(7):1393–1401.
